These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 35764031)
1. Synthesis and biological evaluation of hybrids from optically active ring-opened 3-N-butylphthalide derivatives and 4-fluro-edaravone as potential anti-acute ischemic stroke agents. Jia J; Wu J; Ji D; Jiao W; Wang X; Huang Z; Zhang Y Bioorg Med Chem; 2022 Sep; 69():116891. PubMed ID: 35764031 [TBL] [Abstract][Full Text] [Related]
2. A comparative study of the neuroprotective effects of dl-3-n-butylphthalide and edaravone dexborneol on cerebral ischemic stroke rats. Zhang H; Wang L; Zhu B; Yang Y; Cai C; Wang X; Deng L; He B; Cui Y; Zhou W Eur J Pharmacol; 2023 Jul; 951():175801. PubMed ID: 37207969 [TBL] [Abstract][Full Text] [Related]
3. Human urinary kallidinogenase or edaravone combined with butylphthalide in the treatment of acute ischemic stroke. Qian Y; Lyu Y; Jiang M; Tang B; Nie T; Lu S Brain Behav; 2019 Dec; 9(12):e01438. PubMed ID: 31638334 [TBL] [Abstract][Full Text] [Related]
4. Protective multi‑target effects of DL‑3‑n‑butylphthalide combined with 3‑methyl‑1‑phenyl‑2‑pyrazolin‑5‑one in mice with ischemic stroke. Guan Y; Li P; Liu Y; Guo L; Wu Q; Cheng Y Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34643246 [TBL] [Abstract][Full Text] [Related]
5. Novel hybrids of 3-n-butylphthalide and edaravone: Design, synthesis and evaluations as potential anti-ischemic stroke agents. Sheng X; Hua K; Yang C; Wang X; Ji H; Xu J; Huang Z; Zhang Y Bioorg Med Chem Lett; 2015 Sep; 25(17):3535-40. PubMed ID: 26189079 [TBL] [Abstract][Full Text] [Related]
6. Novel hybrids of optically active ring-opened 3-n-butylphthalide derivative and isosorbide as potential anti-ischemic stroke agents. Wang X; Wang L; Li T; Huang Z; Lai Y; Ji H; Wan X; Xu J; Tian J; Zhang Y J Med Chem; 2013 Apr; 56(7):3078-89. PubMed ID: 23509954 [TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and neuroprotective effects of novel hybrid compounds containing edaravone analogue and 3-n-butylphthalide ring-opened derivatives. Li X; Wang X; Miao L; Guo Y; Yuan R; Tian H Biochem Biophys Res Commun; 2021 Jun; 556():99-105. PubMed ID: 33839420 [TBL] [Abstract][Full Text] [Related]
9. Discovery of a ring-opened derivative of 3-n-butylphthalide bearing NO/H2S-donating moieties as a potential anti-ischemic stroke agent. Yin W; Lan L; Huang Z; Ji J; Fang J; Wang X; Ji H; Peng S; Xu J; Zhang Y Eur J Med Chem; 2016 Jun; 115():369-80. PubMed ID: 27031213 [TBL] [Abstract][Full Text] [Related]
10. Synergistic effects and molecular mechanisms of DL-3-n-butylphthalide combined with dual antiplatelet therapy in acute ischemic stroke. Du Y; Li L; Li X; Tan J; Qin Y; Lv Y; Zhai X Int Immunopharmacol; 2024 Mar; 129():111592. PubMed ID: 38295546 [TBL] [Abstract][Full Text] [Related]
11. Rapid and improved oral absorption of N-butylphthalide by sodium cholate-appended liposomes for efficient ischemic stroke therapy. Zhang A; Li J; Wang S; Xu Y; Li Q; Wu Z; Wang C; Meng H; Zhang J Drug Deliv; 2021 Dec; 28(1):2469-2479. PubMed ID: 34766542 [TBL] [Abstract][Full Text] [Related]
12. Dl-3-n-butylphthalide improves stroke outcomes after focal ischemic stroke in mouse model by inhibiting the pyroptosis-regulated cell death and ameliorating neuroinflammation. Ge M; Jin L; Cui C; Han Y; Li H; Gao X; Li G; Yu H; Zhang B Eur J Pharmacol; 2024 Jul; 974():176593. PubMed ID: 38636800 [TBL] [Abstract][Full Text] [Related]
13. The edaravone and 3-n-butylphthalide ring-opening derivative 10b effectively attenuates cerebral ischemia injury in rats. Hua K; Sheng X; Li TT; Wang LN; Zhang YH; Huang ZJ; Ji H Acta Pharmacol Sin; 2015 Aug; 36(8):917-27. PubMed ID: 26073328 [TBL] [Abstract][Full Text] [Related]
14. Novel 2,6-disubstituted benzofuran-3-one analogues improve cerebral ischemia/reperfusion injury via neuroprotective and antioxidative effects. Yang Z; Luo G; Ying Y; Li H; Wan Y; Xu G; Li M; Xian Y; Feng Y; Fang Y Bioorg Chem; 2023 Mar; 132():106346. PubMed ID: 36638655 [TBL] [Abstract][Full Text] [Related]
15. L-3-n-Butylphthalide reduces ischemic stroke injury and increases M2 microglial polarization. Li F; Ma Q; Zhao H; Wang R; Tao Z; Fan Z; Zhang S; Li G; Luo Y Metab Brain Dis; 2018 Dec; 33(6):1995-2003. PubMed ID: 30117100 [TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of edaravone dexborneol versus dl-3-n-butylphthalide for the treatment of acute ischemic stroke: a Chinese health care perspective. Li J; Cao W; Zhao F; Jin P BMC Public Health; 2024 Feb; 24(1):436. PubMed ID: 38347500 [TBL] [Abstract][Full Text] [Related]
17. Enhanced the treatment of ischemic stroke through intranasal temperature-sensitive hydrogels of edaravone and borneol inclusion complex. Teng C; Lv W; Chen Y; Liu L; Yin J; Li S; Min Z; Zhang Q; He W; Ma K; Li X; Cao X; Xin H Int J Pharm; 2024 Feb; 651():123748. PubMed ID: 38154533 [TBL] [Abstract][Full Text] [Related]
18. Improvement of cerebral ischemia-reperfusion injury by L-3-n-butylphthalide through promoting angiogenesis. Huang Y; Pan L; Wu T Exp Brain Res; 2021 Jan; 239(1):341-350. PubMed ID: 33180154 [TBL] [Abstract][Full Text] [Related]
19. Discovery of a potential anti-ischemic stroke agent: 3-pentylbenzo[c]thiophen-1(3H)-one. Wu J; Ling J; Wang X; Li T; Liu J; Lai Y; Ji H; Peng S; Tian J; Zhang Y J Med Chem; 2012 Aug; 55(16):7173-81. PubMed ID: 22827516 [TBL] [Abstract][Full Text] [Related]
20. DL-3-n-Butylphthalide Ameliorates Post-stroke Emotional Disorders by Suppressing Neuroinflammation and PANoptosis. Cui Y; Hu Z; Wang L; Zhu B; Deng L; Zhang H; Wang X Neurochem Res; 2024 Aug; 49(8):2215-2227. PubMed ID: 38834844 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]